Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News pH-D Feminine Health initiates landmark FDA-cleared Phase 3 trial for boric acid suppositories in yeast infection treatment pH-D Feminine Health begins first FDA-cleared Phase 3 trial for boric acid suppositories, aiming for NDA approval and a breakthrough in recurrent yeast infection treatment. bySoujanya RaviAugust 12, 2025